6:32 PM ET
10-Q
Financial Results
Picard Medical Q3 2026 Results: Net Loss of $2.22M, Loss Narrows
Picard Medical, Inc. is a newly public medical device company focused on total artificial heart therapy, reporting 2,661,574 shares outstanding as of November 12, 2026. The filing highlights significant risks including customer concentration, reliance on single-source suppliers, and an explanatory paragraph from its auditors regarding its ability to continue as a going concern.
- Key figure
- Net loss $2.22M